Research Article
[Retracted] A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
Table 2
General information of patients.
| | Features | Total | FKBP10 upregulated group (n = 22) | FKBP10 downregulated group (n = 20) | value |
| | Age (years) | | | | 0.662 | | ≤55 | 28 | 14 | 14 | | | >55 | 14 | 8 | 6 | | | Gender | | | | 0.537 | | Male | 21 | 12 | 9 | | | Female | 21 | 10 | 11 | | | Tumor size (cm) | | | | 0.014 | | ≤4 | 19 | 6 | 13 | | | >4 | 23 | 16 | 7 | | | TNM staging | | | | 0.005 | | I + II | 22 | 7 | 15 | | | III + IV | 20 | 15 | 5 | | | Degree of differentiation | | | | 0.014 | | Well-differentiated | 19 | 6 | 13 | | | Poorly differentiated | 23 | 16 | 7 | | | Lymphatic metastasis | | | | 0.001 | | Positive | 13 | 12 | 1 | | | Negative | 29 | 10 | 19 | | | Distant metastasis | | | | 0.018 | | Positive | 8 | 7 | 0 | | | Negative | 24 | 15 | 20 | |
|
|
, , and ; downregulated group vs. upregulated group. |